BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19246116)

  • 1. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer.
    Bulut I; Meral M; Kaynar H; Pirim I; Bilici M; Gorguner M
    Lung Cancer; 2009 Nov; 66(2):231-6. PubMed ID: 19246116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
    Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
    Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
    Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.
    Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K
    Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer.
    Ohno K; Utsumi T; Sasaki Y; Suzuki Y
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):492-6. PubMed ID: 15037260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease.
    Grubić Z; Zunec R; Peros-Golubicić T; Tekavec-Trkanjec J; Martinez N; Alilović M; Smojver-Jezek S; Kerhin-Brkljacić V
    Tissue Antigens; 2007 Oct; 70(4):301-6. PubMed ID: 17767551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
    Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
    Goto I; Yoneda S; Yamamoto M; Kawajiri K
    Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
    Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
    Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparanase and vascular endothelial growth factor expression in non-small-cell lung cancer].
    Gao X; Liang QZ; Wu XQ; Li SY; Bai HL; Zhang SL; Qi MX; Yuan WY; Wang JW; Wang GB
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):210-3. PubMed ID: 12901827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.